Clinical Trial Update: Hemodynamic Effects of Dexmedetomidine in Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the hemodynamic effects of dexmedetomidine in septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Septic Shock | Phase 3 | Status: COMPLETED